Franklin Resources Inc Arcutis Biotherapeutics, Inc. Transaction History

Franklin Resources Inc

$330 Billion
Q1 2025

A detailed history of Franklin Resources Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 2,761,767 shares of ARQT stock, worth $37.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,761,767

Previous 3,309,319 16.55%

Holding current value

$37.3 Million

Previous $46.1 Million 6.3%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$11.4 - $17.29 $6.24 Million - $9.47 Million	-547,552 Reduced 16.55%	2,761,767 $43.2 Million
Q4 2024 Feb 12, 2025	SELL	$8.31 - $14.99 $7.82 Million - $14.1 Million	-941,099 Reduced 22.14%	3,309,319 $46.1 Million
Q3 2024 Nov 12, 2024	SELL	$8.32 - $11.0 $1.56 Million - $2.07 Million	-187,761 Reduced 4.23%	4,250,418 $39.5 Million
Q2 2024 Aug 14, 2024	SELL	$7.24 - $12.53 $1.48 Million - $2.56 Million	-204,281 Reduced 4.4%	4,438,179 $41.3 Million
Q1 2024 May 13, 2024	SELL	$3.25 - $11.77 $42,523 - $153,998	-13,084 Reduced 0.28%	4,642,460 $46 Million
Q4 2023 Feb 09, 2024	BUY	$1.84 - $4.82 $6.19 Million - $16.2 Million	3,363,191 Added 260.24%	4,655,544 $15 Million
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $1.91 Million - $3.95 Million	-360,183 Reduced 21.8%	1,292,353 $6.86 Million
Q2 2023 Aug 11, 2023	BUY	$7.51 - $15.0 $444,336 - $887,490	59,166 Added 3.71%	1,652,536 $15.7 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $8.14 Million - $13.6 Million	795,634 Added 99.74%	1,593,370 $17.5 Million
Q4 2022 Feb 10, 2023	SELL	$13.96 - $20.4 $17,589 - $25,704	-1,260 Reduced 0.16%	797,736 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $91,035 - $137,445	5,100 Added 0.64%	798,996 $15.3 Million
Q2 2022 Aug 11, 2022	BUY	$16.33 - $22.2 $2.19 Million - $2.98 Million	134,060 Added 20.32%	793,896 $16.9 Million
Q1 2022 May 13, 2022	BUY	$14.38 - $22.79 $634,028 - $1 Million	44,091 Added 7.16%	659,836 $12.7 Million
Q4 2021 Feb 11, 2022	BUY	$14.98 - $25.5 $607,244 - $1.03 Million	40,537 Added 7.05%	615,745 $12.8 Million
Q3 2021 Nov 12, 2021	SELL	$19.28 - $27.1 $10,025 - $14,092	-520 Reduced 0.09%	575,208 $13.7 Million
Q2 2021 Aug 13, 2021	SELL	$24.42 - $34.75 $1.89 Million - $2.69 Million	-77,280 Reduced 11.83%	575,728 $15.7 Million
Q1 2021 May 13, 2021	BUY	$24.47 - $36.98 $16 Million - $24.1 Million	653,008 New	653,008 $18.9 Million

Others Institutions Holding ARQT

# of Institutions

252

Shares Held

126M

Call Options Held

605K

Put Options Held

170K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $813M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Arcutis Biotherapeutics, Inc. Transaction History